Related Experiment Videos
Changing indications for preimplantation genetic diagnosis (PGD)
1Department of Obstetrics and Gynecology, Baylor College of Medicine, 6550 Fannin, Suite 901A, Houston, TX 77030, USA. jsimpson@bcm.tmc.edu
Molecular and Cellular Endocrinology
|September 29, 2001
Summary
Preimplantation genetic diagnosis (PGD) offers new hope for couples undergoing assisted reproductive technology (ART). Aneuploidy testing via PGD for euploid embryo transfer is a major advancement, potentially improving success rates and aiding those with recurrent pregnancy loss.
Area of Science:
- Reproductive Medicine
- Genetics
- Embryology
Background:
- Preimplantation genetic diagnosis (PGD) is a valuable tool in prenatal genetic diagnosis.
- Traditional indications for PGD are well-established.
- Emerging applications of PGD warrant exploration.
Purpose of the Study:
- To explore novel indications for preimplantation genetic diagnosis (PGD).
- To highlight the potential of aneuploidy testing for euploid embryo transfer.
- To discuss the impact of PGD on assisted reproductive technology (ART) outcomes.
Main Methods:
- Review of current PGD applications and potential future uses.
- Analysis of aneuploidy testing as a novel PGD indication.
- Consideration of PGD's role in managing recurrent IVF failures and spontaneous abortions.
Main Results:
- Aneuploidy testing for euploid embryo transfer is identified as a major new indication for PGD.
- This approach may enhance fertilization success in ART cycles.
- PGD for aneuploidy holds promise for couples with repeated IVF failures or recurrent miscarriages.
Conclusions:
- PGD has evolving indications beyond traditional uses.
- Aneuploidy testing represents a significant advancement in PGD.
- Future applications of PGD are anticipated to expand, improving ART and reproductive outcomes.